Paradigm Medical Industries, Inc. (PDMI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (12,200.00%)
At close: Aug 21, 2025
PDMI Revenue
Paradigm Medical Industries had revenue of $181.00K in the quarter ending March 31, 2012, a decrease of -7.65%. This brings the company's revenue in the last twelve months to $757.00K, down -5.02% year-over-year. In the year 2011, Paradigm Medical Industries had annual revenue of $772.00K with 6.34% growth.
Revenue (ttm)
757.00K
Revenue Growth
-5.02%
P/S Ratio
0.53
Revenue / Employee
126.17K
Employees
6
Market Cap
399.60K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2011 | 772.00K | 46.00K | 6.34% |
Dec 31, 2010 | 726.00K | -132.00K | -15.38% |
Dec 31, 2009 | 858.00K | -401.00K | -31.85% |
Dec 31, 2008 | 1.26M | -613.00K | -32.75% |
Dec 31, 2007 | 1.87M | -323.00K | -14.72% |
Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |